Jacobs Levy Equity Management, Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $879,710 - $1.17 Million	-33,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $20,088 - $41,256	-5,400 Reduced 13.88%	33,500 $242,000
Q4 2017 Feb 13, 2018	BUY	$3.14 - $4.5 $122,146 - $175,050	38,900	38,900 $143,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.